Kanjinti
Generic name:trastuzumab [ tras-TOO-zoo-mab ]
Brand names: Herceptin, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera
What is Kanjinti?
Kanjinti is used to treat certain types of breast cancer or stomach cancer, sometimes in combination with other cancer medicines.
Kanjinti is sometimes used when the cancer has spread to other parts of the body (metastatic).
Kanjinti may also be used for purposes not listed in this medication guide.
Warnings
Do not use if you are pregnant. Use effective birth control, and tell your doctor if you become pregnant during treatment.
Kanjinti can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines.
Some side effects may occur during the injection. Tell your caregivers if you feel dizzy, nauseated, light-headed, weak, short of breath, or if you have a headache, fever, or chills.
Before taking this medicine
Tell your doctor if you have ever had:
heart disease;
congestive heart failure;
a heart attack; or
any allergies or breathing problems.
Kanjinti can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines (such as daunorubicin, doxorubicin, epirubicin, or idarubicin).
You may need to have a negative pregnancy test before starting this treatment.
Do not use Kanjinti if you are pregnant. Kanjinti can cause injury or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 7 months after your last dose. Tell your doctor if you become pregnant.
If you become pregnant while using Kanjinti or within 7 months after you stop, your name may be listed on a pregnancy registry to track the effects of trastuzumab on the baby.
It may not be safe to breastfeed while using this medicine and for up to 7 months after your last dose. Ask your doctor about any risk.
How is Kanjinti given?
Your doctor will perform a medical test to make sure Kanjinti is the right medicine to treat your cancer.
Kanjinti is given as an infusion into a vein. A healthcare provider will give you this injection.
Kanjinti is usually given once every week or every 1 to 3 weeks...
